US equities |
NVDA $237.78 ▲+1.64% SPCX $167.84 ▲+5.58% MU $1,063.54 ▼-1.06% TSLA $379.03 ▲+2.28% MSFT $525.00 ▲+1.44% SNDK $1,711.03 ▼-0.52% INTC $117.00 ▼-1.95% META $742.10 ▲+1.93%
FinancialContent

IDEXX Laboratories, Inc. - Common Stock (NQ:IDXX)

526.72 +8.33 (+1.61%)
Delayed Quote Updated: 2:10 PM EDT, Oct 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about IDEXX Laboratories, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
News headline image
IDEXX Laboratories to Release 2026 Third Quarter Financial Results
From IDEXX Laboratories, Inc.
Via Business Wire
News headline image
IDEXX Laboratories Highlights Diagnostic Pipeline, Reaffirms Long-Term Growth Targets ↗
IDEXX Laboratories (NASDAQ:IDXX) executives highlighted the company’s diagnostic innovation pipeline, recurring-revenue growth and commercial investments during the Morgan Stanley Global Healthcare... 
Via MarketBeat
Topics ETFs
News headline image
IDEXX Highlights Diagnostics Growth Drivers, Cancer Testing at Morgan Stanley Conference ↗
IDEXX Laboratories (NASDAQ:IDXX) executives reiterated the company’s long-term growth framework at the Morgan Stanley Global Healthcare Conference, citing demand for veterinary diagnostics, product... 
Via MarketBeat
Topics ETFs
News headline image
IDEXX Laboratories Acquires CoVetAI to Advance Veterinary Workflow Intelligence
From IDEXX Laboratories, Inc.
Via Business Wire
IDEXX Laboratories (NASDAQ:IDXX) Shares Rise on Q2 Earnings Beat and Improved Outlook ↗
Via Chartmill
Topics Earnings
News headline image
Insider Alert: IDEXX Director Lawrence Kingsley Sells $1.2 Million of Stock ↗
Kingsley exercised options at $114.17 per share before immediately selling at $532.08, capturing a significant gain. His direct stake remains at 9,568 shares worth $5.12 million. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
IDEXX Laboratories to Participate in Morgan Stanley 24th Annual Global Healthcare Conference
From IDEXX Laboratories, Inc.
Via Business Wire
News headline image
IDEXX Laboratories Targets $45B Pet Diagnostics Opportunity With AI, Cancer Tests ↗
IDEXX Laboratories (NASDAQ:IDXX) outlined an innovation-led growth strategy at its 2026 Investor Day, highlighting a $45 billion global companion-animal testing opportunity, expanded commercial... 
Via MarketBeat
Topics Artificial Intelligence ETFs
IDEXX Laboratories (NASDAQ:IDXX) Beats and Raises on Strong Demand, Sending Shares Up ↗
Via Chartmill
IDEXX Laboratories Inc (NASDAQ:IDXX) Passes Caviar Cruise Quality Screen With Strong Fundamentals ↗
Via Chartmill
News headline image
IDEXX (IDXX) Q2 2026 Earnings Call Transcript ↗
Diagnostic innovations fuel 10% CAG recurring revenue growth despite wellness visit pressure. 
Via The Motley Fool
Topics Earnings
News headline image
IDEXX Expands Catalyst Platform into Cardiac Disease with First and Only Dual-Species Point-of-Care NT-proBNP Test
From IDEXX Laboratories, Inc.
Via Business Wire
News headline image
IDEXX Laboratories Q2 Earnings Call Highlights ↗
IDEXX Laboratories (NASDAQ:IDXX) reported second-quarter 2026 revenue growth of approximately 10% on a reported basis and 9% organically, driven by companion animal diagnostics, water and livestock,... 
Via MarketBeat
Topics ETFs Earnings
News headline image
IDEXX Laboratories Q2 2026 Earnings Call Transcript ↗
IDEXX Laboratories (NASDAQ:IDXX) reported second-quarter financial results on Tuesday. The transcript from the company's second-quarter earnings call has been provided below. This transcript is brought... 
Via Benzinga
Topics Earnings
News headline image
IDEXX Laboratories Announces Second Quarter Results
From IDEXX Laboratories, Inc.
Via Business Wire
News headline image
IDEXX Releases 2025 Corporate Responsibility Report, Highlighting Progress Against Its Goals
From IDEXX Laboratories, Inc.
Via Business Wire
Which S&P500 stocks are moving on Wednesday? ↗
Via Chartmill
These S&P500 stocks are moving in today's session ↗
Via Chartmill
News headline image
These 3 Water ETFs Could be Quiet Winners From Infrastructure Spending ↗
As data centers strain water systems, FIW, PHO, and CGW offer investors ETF-based access to water utilities, infrastructure, and equipment firms, each with distinct fees and concentration. 
Via MarketBeat
Topics Artificial Intelligence ETFs
News headline image
IDEXX Laboratories to Release 2026 Second Quarter Financial Results
From IDEXX Laboratories, Inc.
Via Business Wire
News headline image
IDEXX Laboratories Touts AI Push, inVue Dx Momentum at Stifel Conference ↗
IDEXX Laboratories (NASDAQ:IDXX) President and CEO Michael Erickson used a Stifel investor conference appearance to emphasize the company’s innovation pipeline, expanding commercial reach and growing... 
Via MarketBeat
Topics Artificial Intelligence
News headline image
IDEXX Expands Fecal Dx Antigen Testing Platform with Taeniid Tapeworm Detection
From IDEXX Laboratories, Inc.
Via Business Wire
News headline image
IDEXX SDMA Now Integrated into the Most Common Catalyst Chemistry Profiles
From IDEXX Laboratories, Inc.
Via Business Wire
News headline image
IDEXX Laboratories to Present at Stifel Conference and Announces 2026 Investor Day
From IDEXX Laboratories, Inc.
Via Business Wire
Explore the top gainers and losers within the S&P500 index in today's session. ↗
Via Chartmill
News headline image
Idexx (IDXX) Q1 2026 Earnings Call Transcript ↗
Idexx (IDXX) Q1 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
Which S&P500 stocks are moving before the opening bell on Tuesday? ↗
Via Chartmill
News headline image
IDEXX Laboratories Announces First Quarter Results
From IDEXX Laboratories, Inc.
Via Business Wire
Top gainers and losers in the S&P500 index during Thursday's after-hours session. ↗
Via Chartmill
News headline image
IDEXX Laboratories to Release 2026 First Quarter Financial Results
From IDEXX Laboratories, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >